Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FARNESYLTRANSFERASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tamanoi, F; Gau, CL; Jiang, C; Edamatsu, H; Kato-Stankiewicz, J
      Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells

      CELLULAR AND MOLECULAR LIFE SCIENCES
    2. Brown, JM
      Therapeutic targets in radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    3. Teng, S; Sun, JZ; Irby, R; Hamilton, AD; Sebti, S; Yeatman, TJ
      v-Src transformation is mediated through farnesylated proteins

      JOURNAL OF SURGICAL RESEARCH
    4. Kurimoto, M; Hirashima, Y; Ogiichi, T; Hamada, H; Kamiyama, H; Endo, S
      Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis Type 1

      JOURNAL OF NEUROSURGERY
    5. Morgan, MA; Dolp, O; Reuter, CWM
      Cell-cycle-dependent activation of mitogen-activated protein kinase kinase(MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling

      BLOOD
    6. Mizukami, Y; Ura, H; Obara, T; Habiro, A; Izawa, T; Osanai, M; Yanagawa, N; Tanno, S; Kohgo, Y
      Requirement of c-Jun N-terminal kinase for apoptotic cell death induced byfarnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    7. Bell, IM
      Inhibitors of protein prenylation 2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    8. Takeuchi, M; Shichinohe, T; Senmaru, N; Miyamoto, M; Fujita, H; Takimoto, M; Kondo, S; Katoh, H; Kuzumaki, N
      The dominant negative H-ras mutant, N116Y, suppresses growth of metastatichuman pancreatic cancer cells in the liver of nude mice

      GENE THERAPY
    9. Kerbel, RS; Viloria-Petit, A; Klement, G; Rak, J
      'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples

      EUROPEAN JOURNAL OF CANCER
    10. Calderone, A; Abdelaziz, N; Colombo, F; Schreiber, KL; Rindt, H
      A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy andgene expression

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    11. Liu, AX; Prendergast, GC
      Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors

      FEBS LETTERS
    12. O'Connell, CE; Rowell, CA; Ackermann, K; Garcia, AM; Lewis, MD; Kowalczyk, JJ
      Synthesis and evaluation of some hydroxyproline-derived peptidomimetics asisoprenyltransferase inhibitors

      CHEMICAL & PHARMACEUTICAL BULLETIN
    13. Cohen, LH; Pieterman, E; van Leeuwen, REW; Overhand, M; Burm, BEA; van der Marel, GA; van Boom, JH
      Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics

      BIOCHEMICAL PHARMACOLOGY
    14. Ahmed, N; Anderson, SM; Berridge, MV
      IL-3 induces apoptosis in a ras-transformed myeloid cell line

      APOPTOSIS
    15. Williams, TM
      Inhibitors of protein prenylation 1999

      EXPERT OPINION ON THERAPEUTIC PATENTS
    16. Gu, WZ; Tahir, SK; Wang, YC; Zhang, HC; Cherian, SP; O'Connor, S; Leal, JA; Rosenberg, SH; Ng, SC
      Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo

      EUROPEAN JOURNAL OF CANCER
    17. Petit, T; Izbicka, E; Lawrence, RA; Bishop, WR; Weitman, S; Von Hoff, DD
      Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units

      ANNALS OF ONCOLOGY
    18. End, DW
      Farnesyl protein transferase inhibitors and other therapies targeting the ras signal transduction pathway

      INVESTIGATIONAL NEW DRUGS
    19. Caliendo, G; Fiorino, F; Grieco, P; Perissutti, E; De Luca, S; Giuliano, A; Santelli, G; Califano, D; Severino, B; Santagada, V
      Synthesis and biological activity of pseudopeptides inhibitors of Ras farnesyl transferase containing unconventional amino acids

      FARMACO
    20. VIGUSHIN DM; POON GK; BODDY A; ENGLISH J; HALBERT GW; PAGONIS C; JARMAN M; COOMBES RC
      PHASE-I AND PHARMACOKINETIC STUDY OF D-LIMONENE IN PATIENTS WITH ADVANCED CANCER

      Cancer chemotherapy and pharmacology
    21. CALIENDO G; FIORINO F; GRIECO P; PERISSUTTI E; RAMUNNO A; SANTAGADA V; ALBRIZIO S; CALIFANO D; GIULIANO A; SANTELLI G
      PHENOL-DERIVED CVFM ANALOG INHIBITORS OF RAS FARNESYLTRANSFERASE POSSESSING CELLULAR IN-VITRO ACTIVITY

      European journal of medicinal chemistry
    22. KAINUMA O; ASANO T; HASEGAWA M; KENMOCHI T; NAKAGOHRI T; TOKORO Y; ISONO K
      INHIBITION OF GROWTH AND INVASIVE ACTIVITY OF HUMAN PANCREATIC-CANCERCELLS BY A FARNESYLTRANSFERASE INHIBITOR, MANUMYCIN

      Pancreas
    23. LANTRY LE; ZHANG ZQ; GAO F; CRIST KA; WANG Y; KELLOFF GJ; LUBET RA; YOU M
      CHEMOPREVENTIVE EFFECT OF PERILLYL ALCOHOL ON 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE INDUCED TUMORIGENESIS IN (C3H HEJ-X-A/J)F-1 MOUSE LUNG/

      Journal of cellular biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 00:49:21